They specifically target collagen type 1-3 in the areas theyre injected meaning they dont affect all collagen in that area, they specifically target the type of collagen that forms fibrous septae, which are the bands that tether the skin to the fascia and muscle below
Researchers compare drops to capsules or injectables based on stability, absorption models, and experimental design rather than consumer use
30-50% of patients experience CIPN with low dose regimens but at higher doses as many as 90% of patients experience neuropathy making it an important dose limiting toxicity (1)
Litman T, Zeuthen T, Skovsgaard T, Stein WD
Anti-inflammatory and tissue repair properties may help address the systemic inflammatory burden
Amelioration of age associated neuroinflammation on Long term bacosides treatment